![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
PJ Chiu, S Vemulapalli, C Sabin, M Rivelli, V Bernardino and EJ Sybertz
Department of Pharmacology, Schering-Plough Research Institute, Bloomfield, New Jersey.
The possible role of sympathoadrenal stimulation and endothelin release in cyclosporine (CS)-induced hypertension was ascertained in intact and pithed rats. CS (20 and 40 mg/kg), administered by i.v. infusion over 10 min, produced a dose-dependent increase in blood pressure: 19 +/- 5 and 31 +/- 2 mm Hg in intact rats and 13 +/- 4 and 18 +/- 2 mm Hg in pithed rats. In intact rats, pretreatment with reserpine (5 mg/kg, i.p.) or hexamethonium (10 mg/kg, i.v.) greatly blunted the pressor responses to CS (40 mg/kg) (7 +/- 3 and 11 +/- 2 mm Hg, respectively). In pithed rats, the blood pressure responses to CS (40 mg/kg) were significantly impaired, but were not further modified by phenoxybenzamine (3 mg/kg, i.v.), whereas adrenalectomy completely abolished the CS-induced pressor responses (0 +/- 1 mm Hg). CS (40 mg/kg) did not potentiate pressor responses to sympathetic nerve stimulation (0.1 and 0.3 Hz) or vasoconstrictors, including angiotensin II (0.03 microgram/kg, i.v.), phenylephrine (1 microgram/kg, i.v.) and arginine vasopressin (0.075 microgram/kg) in pithed rats. In addition, CS (40 mg/kg, i.v.) did not cause elevation of plasma immunoreactive endothelin-1 and -3. Furthermore, phosphoramidon (0.25 mg/kg/min x 30) abolished pressor response to big endothelin-1 (5 micrograms/kg, i.v.) but failed to affect CS-induced hypertension. It is concluded that the acute blood pressure response to CS manifests great dependence on sympathetic nervous system but appears independent of endothelin release.
This article has been cited by other articles:
|
|
 |
|
  H. Liu, W. Ye, G. Guan, Z. Dong, Z. Jia, and T. Yang Developmental regulation of calcineurin isoforms in the rodent kidney: association with COX-2 Am J Physiol Renal Physiol, December 1, 2007; 293(6): F1898 - F1904. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. M. El-Mas, E. A. Afify, A. G. Omar, and F. M. Sharabi Cyclosporine Adversely Affects Baroreflexes via Inhibition of Testosterone Modulation of Cardiac Vagal Control J. Pharmacol. Exp. Ther., April 1, 2002; 301(1): 346 - 354. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Zhang Old and new tools to dissect calcineurin's role in pressure-overload cardiac hypertrophy Cardiovasc Res, February 1, 2002; 53(2): 294 - 303. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Zhang, J.-L. Li, M. Hosaka, R. Janz, J. M. Shelton, G. M. Albright, J. A. Richardson, T. C. Südhof, and R. G. Victor Cyclosporine A-induced hypertension involves synapsin in renal sensory nerve endings PNAS, July 30, 2000; (2000) 170160397. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. Ryuzaki, L. K. Stahl, T. Lyson, R. G. Victor, and V. S. Bishop Sympathoexcitatory Response to Cyclosporin A and Baroreflex Resetting Hypertension, February 1, 1997; 29(2): 576 - 582. [Abstract] [Full Text]
|
|
|
|
|
|
C. M. Stein, H. He, T. Pincus, and A. J.J. Wood Cyclosporine Impairs Vasodilation Without Increased Sympathetic Activity in Humans Hypertension, October 1, 1995; 26(4): 705 - 710. [Abstract] [Full Text]
|
|
|
|
|
|
W. Zhang, J.-L. Li, M. Hosaka, R. Janz, J. M. Shelton, G. M. Albright, J. A. Richardson, T. C. Sudhof, and R. G. Victor Cyclosporine A-induced hypertension involves synapsin in renal sensory nerve endings PNAS, August 15, 2000; 97(17): 9765 - 9770. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
